Nasdaq · Healthcare
ICON PLC (ICLR)
As-reported financials and recent SEC filings for ICON PLC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$8.25B
Net income
$229.3M
Net margin
2.8%
Diluted EPS
$2.90
ROE
2.5%
P/E (TTM)
74.5×
Market cap
$13.01B
Debt / equity
0.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $8.25B | $8.19B | $8.05B | $7.74B | $5.48B |
| Gross profit | — | $2.34B | $2.33B | $2.21B | $1.51B |
| Operating income | $442.8M | $1.03B | $904.7M | $795.2M | $378.5M |
| Net income | $229.3M | $739.1M | $554.2M | $505.3M | $153.2M |
| Diluted EPS | $2.90 | $8.90 | $6.70 | $6.13 | $2.25 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
6-K2026-06-26
View on EDGAR →6-K2026-06-23
View on EDGAR →6-K2026-06-23
View on EDGAR →6-K2026-06-17
View on EDGAR →32026-06-05
View on EDGAR →32026-06-05
View on EDGAR →6-K2026-05-27
View on EDGAR →6-K/A2026-05-27
View on EDGAR →Go deeper on ICLR
Search ICON PLC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.